[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.209.213. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
March 1992

Lymphadenectomy in Gastric CarcinomaA Prospective and Prognostic Study

Author Affiliations

From the Department of Surgery, Clinic for Abdominal and Transplantation Surgery (Drs Jaehne, Meyer, Bruns, and Pichlmayr), Institute of Pathology (Dr Maschek), and Institute of Biometrics (Dr Geerlings), Medical School Hannover (Federal Republic of Germany). Dr Jaehne is now with the Clinic for Abdominal and Transplantation Surgery, Medizinische Hochschule Hannover, Hannover, Federal Republic of Germany.

Arch Surg. 1992;127(3):290-294. doi:10.1001/archsurg.1992.01420030052010
Abstract

• In 193 gastric resections for adenocarcinoma, lymphadenectomy was prospectively evaluated to quantify the number of lymph nodes and to identify prognostic factors. Overall, 7112 nodes (median, 36.8 per patient) were resected with 27.2% showing metastases. Most nodes were found in the perigastric region. The histologic type and site of the tumor did not influence the number of invaded nodes, but tumor stage and quality of the resection (curative/palliative) did. By multivariate analysis the tumor stage, curative vs palliative resections, and the number of metastatic lymph nodes in curative resections were independent prognostic factors. Patients with less than six metastatic nodes showed a survival not significantly different from that of patients with normal nodes. These patients may be well treated by surgery alone, but the other patients may require multimodal therapy to improve their prognosis.

(Arch Surg. 1992;127:290-294)

×